These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10426356)

  • 1. From enhancing lesions to brain atrophy in relapsing MS.
    Simon JH
    J Neuroimmunol; 1999 Jul; 98(1):7-15. PubMed ID: 10426356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Simon JH; Jacobs LD; Campion MK; Rudick RA; Cookfair DL; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Simonian N; Lajaunie M; Miller DE; Wende K; Martens-Davidson A; Kinkel RP; Munschauer FE; Brownscheidle CM
    Neurology; 1999 Jul; 53(1):139-48. PubMed ID: 10408550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and atrophy in multiple sclerosis: MRI associations with disease course.
    Lin X; Blumhardt LD
    J Neurol Sci; 2001 Aug; 189(1-2):99-104. PubMed ID: 11535239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.
    Leist TP; Gobbini MI; Frank JA; McFarland HF
    Arch Neurol; 2001 Jan; 58(1):57-60. PubMed ID: 11176937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging intensity modeling of damage and repair in multiple sclerosis: relationship of short-term lesion recovery to progression and disability.
    Meier DS; Weiner HL; Guttmann CR
    AJNR Am J Neuroradiol; 2007; 28(10):1956-63. PubMed ID: 17998417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V; Suri S; Bakshi R
    Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
    Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
    Paolillo A; Pozzilli C; Gasperini C; Giugni E; Mainero C; Giuliani S; Tomassini V; Millefiorini E; Bastianello S
    J Neurol Sci; 2000 Mar; 174(2):85-91. PubMed ID: 10727693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study.
    Lin X; Blumhardt LD; Constantinescu CS
    Acta Neurol Scand; 2003 Dec; 108(6):401-6. PubMed ID: 14616292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
    Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
    Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term ventricular volume changes on serial MRI in multiple sclerosis.
    Redmond IT; Barbosa S; Blumhardt LD; Roberts N
    Acta Neurol Scand; 2000 Aug; 102(2):99-105. PubMed ID: 10949526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
    Liu C; Edwards S; Gong Q; Roberts N; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):323-30. PubMed ID: 10084530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
    Radue EW; O'Connor P; Polman CH; Hohlfeld R; Calabresi P; Selmaj K; Mueller-Lenke N; Agoropoulou C; Holdbrook F; de Vera A; Zhang-Auberson L; Francis G; Burtin P; Kappos L;
    Arch Neurol; 2012 Oct; 69(10):1259-69. PubMed ID: 22751847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.
    Jakimovski D; Gandhi S; Paunkoski I; Bergsland N; Hagemeier J; Ramasamy DP; Hojnacki D; Kolb C; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Eur J Neurol; 2019 Jan; 26(1):87-e8. PubMed ID: 30103277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.